Predictive Oncology Completes Acquisition of Quantitative Medicine
MINNEAPOLIS, July 07, 2020 (GLOBE NEWSWIRE) — Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) […]
Airband Leverages DZS Technology to Bring Gigabit Broadband Services to Rural Communities Across the UK
ALAMEDA, Calif., July 07, 2020 (GLOBE NEWSWIRE) — DASAN Zhone Solutions, Inc. (NSDQ: DZSI or “DZS”), a leading enabler of […]
Outlook Therapeutics Completes Patient Enrollment for NORSE 2 Study of ONS-5010 / LYTENAVA™ (bevacizumab-vikg)
Pivotal NORSE 2 safety and efficacy data expected to be reported in the third calendar quarter of 2021 ONS-5010 / LYTENAVA™Bay […]
ImmuCell Announces Preliminary, Unaudited Sales Results for the Second Quarter Ended June 30, 2020
PORTLAND, Maine, July 07, 2020 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company […]
Diffusion Pharmaceuticals Files IND for International Phase 1b/2b COVID-19 Clinical Program With TSC
Phase 1b dosing expected to begin this month Data read-out expected later this quarterCHARLOTTESVILLE, Va., July 07, 2020 (GLOBE NEWSWIRE) — […]
Hub Group Named to Supply & Demand Chain Executive’s SDCE 100 Top Supply Chain Projects for 2020
OAK BROOK, Ill., July 07, 2020 (GLOBE NEWSWIRE) — Supply & Demand Chain Executive has selected Hub Group Inc. (NASDAQ:HUBG) […]
Atlantic Union Bankshares Corporation to Release Second Quarter 2020 Results
RICHMOND, Va., July 07, 2020 (GLOBE NEWSWIRE) — Atlantic Union Bankshares Corporation today announced that it will release second quarter […]
Syneos Health Bolsters Communications Leadership Team
Tim Pantello Appointed to Lead One of the World’s Largest Healthcare-Only Agency PortfoliosJoined by a Trio of Senior Hires with […]
Cabaletta Bio and Artisan Bio Announce Gene Editing Research and Collaboration Agreement to Develop Next-Generation CAAR T Cell Therapies
PHILADELPHIA and DENVER, July 07, 2020 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on […]
Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement For Repotrectinib in Greater China
Zai Lab Granted Exclusive Rights to Develop and Commercialize Repotrectinib in Greater ChinaTurning Point to Receive $25 Million Upfront, Potential […]
